Lung toxicity following fludarabine, cytosine arabinoside and mitoxantrone (flan) treatment for acute leukemia.
Salvucci
M
M
Zanchini
R
R
Molinari
A
A
Zuffa
E
E
Poletti
V
V
Poletti
G
G
Zaccaria
A
A
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity*; D003561:Cytarabine / Q000008:administration & dosage / Q000633:toxicity; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D007231:Infant, Newborn; D007938:Leukemia / Q000150:complications / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000188:drug therapy; D008171:Lung Diseases / Q000139:chemically induced* / Q000150:complications; D008297:Male; D008942:Mitoxantrone / Q000008:administration & dosage / Q000633:toxicity; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000188:drug therapy; D012127:Respiratory Distress Syndrome, Newborn / Q000139:chemically induced; D013203:Staphylococcal Infections / Q000139:chemically induced; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000633:toxicity
D003561:Cytarabine; D008942:Mitoxantrone; D014740:Vidarabine; C024352:fludarabine